With personalized or precision medicine—medical decisions, practices, and interventions can now be tailored to the individual patients. Learn how the recent growth of new diagnostic and informatics approaches can provide understanding of the molecular basis of bladder cancer. Learn how our improved understanding of genomics (the study of your genes) is being used to change the bladder cancer treatment landscape. Can this knowledge be used to predict your response or risks from different treatments? Find out how recently approved targeted therapies are being used in diagnosis and treatment to improve patient outcomes.
Featuring urologist Dr. Seth P. Lerner, Baylor College of Medicine and medical oncologist, Dr. Gopa Iyer from Memorial Sloan Kettering Cancer Institute.